awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44182147-314CDA75-1CD0-45D6-9807-8D6DD3B70F4D
Q44182147-314CDA75-1CD0-45D6-9807-8D6DD3B70F4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44182147-314CDA75-1CD0-45D6-9807-8D6DD3B70F4D
D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment.
P2860
Q44182147-314CDA75-1CD0-45D6-9807-8D6DD3B70F4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44182147-314CDA75-1CD0-45D6-9807-8D6DD3B70F4D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c644d40a333be9badd80950fe9bfc290c9046743
P2860
Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.